EXPRESSION OF PROPERDIN IN HUMAN MONOCYTES

被引:45
作者
SCHWAEBLE, W
HUEMER, HP
MOST, J
DIERICH, MP
STROBEL, M
CLAUS, C
REID, KBM
ZIEGLERHEITBROCK, HWL
机构
[1] UNIV LEICESTER, DEPT IMMUNOL, LEICESTER, ENGLAND
[2] UNIV INNSBRUCK, INST HYG, INNSBRUCK, AUSTRIA
[3] UNIV MUNICH, INST IMMUNOL, MUNICH, GERMANY
[4] UNIV MAINZ, DEPT INTERNAL MED, MAINZ, GERMANY
[5] UNIV OXFORD, DEPT BIOCHEM, MRC, IMMUNOCHEM UNIT, OXFORD, ENGLAND
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 1994年 / 219卷 / 03期
关键词
D O I
10.1111/j.1432-1033.1994.tb18555.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Properdin is the only known positive regulator of the alternative pathway of complement activation. Northern blot analysis of cell lines derived from fibroblasts, B-cells, hepatoma cells, and cells of the monocyte-macrophage lineage revealed properdin expression only in the myelomonocytic cell line HL-60, in the monoblastic cell line U-937 and in the monocytic line Mono Mac 6. Culture of Mono Mac 6 cells for 24 h with phorbol 12-myristate 13-acetate, bacterial lipopolysaccharide and the cytokines interleukin-1 beta and tumour necrosis factor-alpha enhanced mRNA abundance, with the strongest effect (tenfold) being observed with the lipopolysaccharide. In contrast, recombinant interferon-gamma consistently halved properdin mRNA abundance. The same pattern was found for the secretion of properdin as detected by ELISA of Mono Mac 6 supernatants. The suppressive effect of interferon-gamma on properdin mRNA abundance was also demonstrated for primary blood monocytes. The data suggest that the expression and secretion of this complement regulatory protein by monocytes is differentially regulated by cytokines and link the immune response with alternative pathway activation.
引用
收藏
页码:759 / 764
页数:6
相关论文
共 29 条
[1]   NORTHERN BLOT NORMALIZATION WITH A 28S RIBOSOMAL-RNA OLIGONUCLEOTIDE PROBE [J].
BARBU, V ;
DAUTRY, F .
NUCLEIC ACIDS RESEARCH, 1989, 17 (17) :7115-7115
[2]   ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE [J].
CHIRGWIN, JM ;
PRZYBYLA, AE ;
MACDONALD, RJ ;
RUTTER, WJ .
BIOCHEMISTRY, 1979, 18 (24) :5294-5299
[3]   GENETIC AND PHYSICAL MAPPING AROUND THE PROPERDIN-P GENE [J].
COLEMAN, MP ;
MURRAY, JC ;
WILLARD, HF ;
NOLAN, KF ;
REID, KBM ;
BLAKE, DJ ;
LINDSAY, S ;
BHATTACHARYA, SS ;
WRIGHT, A ;
DAVIES, KE .
GENOMICS, 1991, 11 (04) :991-996
[4]  
ELIAS JA, 1987, J IMMUNOL, V138, P3812
[5]  
FARRIES TC, 1989, J IMMUNOL, V142, P842
[6]   A TECHNIQUE FOR RADIOLABELING DNA RESTRICTION ENDONUCLEASE FRAGMENTS TO HIGH SPECIFIC ACTIVITY [J].
FEINBERG, AP ;
VOGELSTEIN, B .
ANALYTICAL BIOCHEMISTRY, 1983, 132 (01) :6-13
[7]   PROPERDIN, THE TERMINAL COMPLEMENT COMPONENTS, THROMBOSPONDIN AND THE CIRCUMSPOROZOITE PROTEIN OF MALARIA PARASITES CONTAIN SIMILAR SEQUENCE MOTIFS [J].
GOUNDIS, D ;
REID, KBM .
NATURE, 1988, 335 (6185) :82-85
[8]  
GOUNDIS D, 1990, GENOMICS, V5, P56
[9]  
HOLME ER, 1989, CLIN EXP IMMUNOL, V76, P76
[10]  
KATZ Y, 1988, J IMMUNOL, V141, P559